Thermo Fisher Scientific is trading 3.07% up at $693.89 on October 15, 2026, after Guggenheim initiated coverage with a Buy rating and a $740 price target, reported Thursday. - Healthcare is up 2.12%, supported by strong earnings and raised guidance from UnitedHealth and Johnson & Johnson. - The defensive-sector backdrop may have added support, while hotter inflation weighed on technology shares.